2,4-Thiazolidinedione,5-(1,3-benzodioxol-5-ylmethylene)-
2,4-Thiazolidinedione,5-(1,3-benzodioxol-5-ylmethylene)- Basic information
- Product Name:
- 2,4-Thiazolidinedione,5-(1,3-benzodioxol-5-ylmethylene)-
- Synonyms:
-
- 2,4-Thiazolidinedione,5-(1,3-benzodioxol-5-ylmethylene)-
- PI 3-Kγ Inhibitor VII - CAS 6318-41-8 - Calbiochem
- Inhibitor,PI3Kγ,inhibit,Phosphoinositide 3-kinase,AS 041164,AS-041164,anti-inflammatory,neutrophil,recruitment,AS041164,RANTES,PI3K
- 5-(Benzo[d][1,3]dioxol-5-ylmethylene)thiazolidine-2,4-dione
- AS-041164, PI3K gamma inhibitor
- AS-041164, 10 mM in DMSO
- PI 3-Kγ Inhibitor VII
- PI 3-Kγ Inhibitor VII
- CAS:
- 6318-41-8
- MF:
- C11H7NO4S
- MW:
- 249.24
- Mol File:
- 6318-41-8.mol
2,4-Thiazolidinedione,5-(1,3-benzodioxol-5-ylmethylene)- Chemical Properties
- Density
- 1.595±0.06 g/cm3(Predicted)
- storage temp.
- +2C to +8C
- solubility
- Soluble in DMSO (up to 25 mg/ml).
- form
- Yellow solid
- pka
- 7.13±0.20(Predicted)
- color
- Yellow
- Stability:
- Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 3 months.
2,4-Thiazolidinedione,5-(1,3-benzodioxol-5-ylmethylene)- Usage And Synthesis
Description
The phosphatidylinositol 3-
Uses
AS-041164 is a potent, selective and orally active PI3Kγ isoform inhibitor with an IC50 of 70 nM. AS-041164 shows less activity against PI3Kα, PI3Kβ, and PI3Kδ (IC50s of 240 nM, 1.45 μM, and 1.70 μM, respectively). AS-041164 has anti-inflammatory effects[1].
in vivo
AS-041164 (10-100 mg/kg; oral administration; once) treatment results in the reduction of inflammatory swelling in the model of carrageenan-induced paw edema[1].
AS-041164 (3-100 mg/kg p.o.) treatment dose-dependently decreases r-h regulated on activation normal T cell expressed and secreted (RANTES)-induced neutrophil recruitment in mice. The ED50 value for AS-041164 is 27.35 mg/kg. AS-041164 blocks RANTES-induced chemotaxis and reduces the level of AKT phosphorylation[1].
Animal Model: | Male Wistar rats (100-150 g) injected with carrageenan[1] |
Dosage: | 10 mg/kg, 30 mg/kg, 100 mg/kg |
Administration: | Oral administration; once |
Result: | Induced a significant reduction of paw thickness. |
IC 50
PI3Kγ: 70 nM (IC50); PI3Kα: 240 nM (IC50); PI3Kβ: 1.4 μM (IC50); PI3Kδ: 1.7 μM (IC50)
References
1) Ferrandi et al. (2007) Phosphoinositide 3-kinase gamma inhibition plays a crucial role in early steps of inflammation by blocking neutrophil recruitment: J. Pharmacol. Exp. Ther. 322 923
2,4-Thiazolidinedione,5-(1,3-benzodioxol-5-ylmethylene)-Supplier
- Tel
- 1-631-485-4226; 16314854226
- info@bocsci.com
- Tel
- 021-65675885 18964387627
- info@efebio.com
- Tel
- 021-61312847; 18021002903
- 3008007409@qq.com
- Tel
- 15076683720
- klq@cw-bio.com
- Tel
- +1-781-999-5354 +1-00000000000
- marketing@targetmol.com